ITRM trade ideas
ITRM, FDA trial to resume?We are down alot on this, hoping for the break and taking back some capital.
$ITRM idea **Not financial advice**
ITRM under $1 whilst being in NASDAQ, will need to reclaim the $1 before february. This will shoot up toward end of year whilst penny stocks are hot. looking to fill that $1.09 gap fill soon. Small amount of volume will send this. 15% risk at lows of 0.50 and potential profits of 87%.
@IbzzB - Twitter
ITRM More potential short term gains?What a dip! I believe we're in a good spot for some short term gains here! Good Luck!
$ITRM Bullish July swing$ITRM PDUFA JULY 25. Expect heavier volume to come in as we get closer to date. First PT 3$, second $4.20, last PT 5$. Take profits on the way up.
$ITRM can rise in the next daysContextual immersion trading strategy idea.
Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing anti-infectives for multi-drug resistant pathogens in Ireland and the United States.
The demand for shares of the company looks higher than the supply.
This and other conditions can cause a rise in the share price in the next days.
So I opened a long position from $2.37;
stop-loss — $2.10.
Information about take-profits will be later.
Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.
If you like my content, you can subscribe to the news and receive my fresh ideas.
Thanks for being with me!
Familiar T/A on ITRM Well, doesn't this look familiar? ITRM tested is previous level of support AND resistance in a wide channel today. IDK what the sell-off was but I'm guessing the re-entry had something to do with speculation on the FDA data set to come out next month.
"At the end of May, Iterum provided an update on its New Drug Application with the U.S. Food and Drug Administration. Currently, the NDA is still under review by the FDA, and the PDUFA goal date is July 25th, 2021. Since the application review for Sulopenem is on track at the moment, ITRM stock is performing well as a result. ITRM stock price has nearly doubled in the last month."
Not sure if it gets the approvals necessary but "buy the rumor" might be playing a role here.
Quote Source: Top 9 Penny Stocks With High Volume to Watch Right Now
Descending Wedge on ITRMI'm new to technical analysis, but this looks like a descending wedge pattern to me. Bullish, needs confirmation of the PDUFA date and can rocket. I listened to their CC this morning, ITRM is in communication and collaboration with FDA. They said as far as they know, the FDA approval can still be late July as planned. I'm bullish, I'd love to hear others thoughts.
ITRM 40% or more coming soon!? These lows and highs are lining up nicely. I see a nice gain coming. $$$
Bought 500 ITRM @$1.60 Target @$8.00 date Jan 10,2022Item Therapeutics, Inc
Bought 500 ITRM @$1.60. Target @$8.00 date Jan 10,2022
Buy limit 500 ITRM @$1.40. Target @$10.00 date May 2,2022
Iterum Therapeutics plc is a clinical-stage pharmaceutical company dedicated to developing significantly
differentiated anti-infectives aimed at combating the global crisis of multi-drug resistant (MDR) pathogens.
Company Website: www.iterumtx.com
Press Release: www.iterumtx.com
FDA Aproval analysis review: youtu.be
ITRM as long bull can hold line support we can go $5 ITRM still looking good if bull can hold line support we can see $5 - $20 from now to July when FDA approve
ITRM LONGHello, everyone.
As we can see in the chart, we are aiming for the points indicated by the two marks.
Check your stop loss.
Good luck.
ITRM to $6Needs to be able to maintain price above the .382 fib level at $2.58, should be able to here in the coming weeks, longer term target of $6 for me.
ITRM LongThe chart has taken support near 2, the uptrend may continue and touch 4.6. SL:1.9. As long as gap near 1.9 doesn't fill chart continues to be strong.
Disclaimer: The stock/index/currency discussed do not constitute Investment/trading advise and is merely an effort towards enhancing learning, knowledge and book keeping. Kindly do your own due diligence and/or consult investment advisor before making any investment/trading decisions
